The WHO framework to prepare for Country Introduction of New TB Vaccines for Adults and Adolescents was designed to support the planning, investments, and preparation for the rapid introduction and scale-up of TB vaccines for adults and adolescents so that…
The World Health Organization's Evidence Considerations for Vaccine Policy Development (ECVP) focuses on TB vaccines intended for adults and adolescents and is designed to support the product development, regulatory approval, introduction, access and widespread use in LMICs of new TB…
Contact: Mike Frick, mike.frick@treatmentactiongroup.org It's a privilege to provide a perspective from civil society at this strategic convening of the TB Vaccine Accelerator Council. The five recommendations coming out of the recent Accelerator Forum make clear just how complex this…
Contact: Mike Frick, TB project co-director, mike.frick@treatmentactiongroup.org November 6 2025, New York — Treatment Action Group (TAG) welcomes the report published today by the World Health Organization TB Vaccine Accelerator Council on how to finance global, equitable access to new…
The World Health Organization's Catalyzing solutions for equitable global access and sustainable financing for novel tuberculosis vaccines for adults and adolescents report assesses country readiness, demand and supply projections, product development pathways and the global financing landscape to understand potential uncertainties…
From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first-of-its-kind analysis of the global supply chains of two key adjuvants used in several of the world’s most…
The 19th iteration of Treatment Action Group (TAG)'s Tuberculosis Research and Development Funding Report analyzes the state of play for dedicated TB R&D funding following the United Nations High Level Meeting on TB in September 2023. Significant acceleration of investment…
What Could Go Right? Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines, explores the foundational role that community and civil society groups can play in the successful introduction of a new TB vaccine and strategies for capacitating…
Communities and civil society organizations are poised to play an indispensable role in ensuring the success of new TB vaccines by building the “infrastructures of trust” that are foundational to vaccine acceptance, demand, and equitable access. What Could Go Right:…
World Health Organization's investment case for new TB vaccines reviews the early evidence on the potential value of investing in the development and introduction of new TB vaccines to guide national and global decision-makers strategy.